All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.

The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Introducing

Now you can personalise
your Lymphoma Hub experience!

Bookmark content to read later

Select your specific areas of interest

View content recommended for you

Find out more
  TRANSLATE

The Lymphoma Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the Lymphoma Hub cannot guarantee the accuracy of translated content. The Lymphoma Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact
LOADING
You're logged in! Click here any time to manage your account or log out.
LOADING
You're logged in! Click here any time to manage your account or log out.
2017-01-11T16:18:05.000Z

ESH Clinical Updates Conference on Aggressive Lymphoma

Jan 11, 2017
Share:

Bookmark this article

The European School of Haematology’s (ESH’s) Clinical Updates on Aggressive Lymphoma conference will take place on the 15–17 February 2017 at the Marriott Rive Gauche Hotel in Paris, France. ESH Clinical Update conferences are aimed at presenting real clinical cases submitted by attendees and analyzing them in an interactive setting while learning from global experts. The focus of this conference is on updating the attendees on the latest diagnostic tools and procedures in addition to the clinical management of aggressive lymphomas including DLBCL, MCL, and CNS lymphoma.

The conference is being chaired by Martin Dreyling, Kieron Dunleavy, and Catherine Thieblemont, and includes presentations, discussion, and debates from other leading experts such as Stefano Luminari, Pier Luigi Zinzani, Simon Rule, and Eva Hoster. Registration is still open for what will be a very educational and engaging conference.

  1. European School of Haematology. Clinical Updates on Aggressive Lymphoma. http://www.esh.org/conference/clinical-updates-on-aggressive-lymphoma/ [Accessed 11/01/17].

Understanding your specialty helps us to deliver the most relevant and engaging content.

Please spare a moment to share yours.

Please select or type your specialty

  Thank you

Your opinion matters

Given there are no currently approved treatment options for patients with Waldenstrom’s macroglobulinemia in the third-line setting, what major response rate threshold would make you consider adopting a new radiotherapy option in this setting?
1 vote - 7 hours left ...

Newsletter

Subscribe to get the best content related to lymphoma & CLL delivered to your inbox